Gene · 3664
Papers2,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment. | Cell Commun Signal | 2023 | 37537585 | PubTator, text mining | PubMed |
| Integrative analysis of transcriptome dynamics during human craniofacial development identifies candidate disease genes. | Nat Commun | 2023 | 37532691 | PubTator, text mining | PubMed |
| Identification of a novel immune-related transcriptional regulatory network in sarcopenia. | BMC Geriatr | 2023 | 37525094 | PubTator, text mining | PubMed |
| Serpin Family A Member 1 Is Prognostic and Involved in Immunological Regulation in Human Cancers. | Int J Mol Sci | 2023 | 37511325 | PubTator, text mining | PubMed |
| An Innovative Three-Stage Model for Prenatal Genetic Disorder Detection Based on Region-of-Interest in Fetal Ultrasound. | Bioengineering (Basel) | 2023 | 37508900 | PubTator, text mining | PubMed |
| Antimicrobial Peptides and Interleukins in Cleft Soft Palate. | Children (Basel) | 2023 | 37508659 | PubTator, text mining | PubMed |
| Efficient Generation of Chondrocytes From Bone Marrow-Derived Mesenchymal Stem Cells in a 3D Culture System: Protocol for a Practical Model for Assessing Anti-Inflammatory Therapies. | JMIR Res Protoc | 2023 | 37505889 | PubTator, text mining | PubMed |
| Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma. | Curr Oncol | 2023 | 37504306 | PubTator, text mining | PubMed |
| The roles of inflammasomes in cancer. | Front Immunol | 2023 | 37497237 | PubTator, text mining | PubMed |
| Severe Typhoid Fever Complicated by Superior Mesenteric and Splenic Vein Thrombosis. | Infect Dis Rep | 2023 | 37489392 | PubTator, text mining | PubMed |
| Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity. | Genome Med | 2023 | 37475040 | PubTator, text mining | PubMed |
| Social Determinants of Child Undernutrition in Adivasi Population in Northern Kerala: A Study Using Syndemic Framework. | Indian J Pediatr | 2023 | 37462817 | PubTator, text mining | PubMed |
| Targeting transcription factors for therapeutic benefit in rheumatoid arthritis. | Front Immunol | 2023 | 37457726 | PubTator, text mining | PubMed |
| Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers. | Explor Target Antitumor Ther | 2023 | 37455825 | PubTator, text mining | PubMed |
| Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy. | Nutrients | 2023 | 37447161 | PubTator, text mining | PubMed |
| New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review. | Cancers (Basel) | 2023 | 37444400 | PubTator, text mining | PubMed |
| Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes. | Mol Metab | 2023 | 37429525 | PubTator, text mining | PubMed |
| Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy. | iScience | 2023 | 37416452 | PubTator, text mining | PubMed |
| Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. | J Cancer Res Clin Oncol | 2023 | 37402968 | PubTator, text mining | PubMed |
| Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy. | Res Sq | 2023 | 37398248 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3664/papers?page=10